Fibrosis

Research identifies key factor leading to cell cycle arrest and fibrosis production in the kidney A new study of how scar tissue is produced in the kidneys has identified potential culprits and promising targets for intervention. The study, published in...

Research in the Harvard Stem Cell Institute (HSCI) Cardiovascular Disease Program centers on ten laboratories at Harvard University and its eight affiliated hospitals. Their shared goal is to develop new treatments for heart disease. “We’re interested in...

Researchers find a new type of lung cell involved in cystic fibrosis By Jessica Lau In cystic fibrosis, mucus builds up in the lungs and leads to breathing difficulties because cells do not properly make the CFTR protein. Although scientists have known...

HSCI, a network of the nation’s top stem cell and regenerative medicine researchers, gathers to exchange ideas and forge new collaborations to advance biomedical research. Summary 2018 gathering of stem cell scientists provided rich ground for knowledge...

Boehringer Ingelheim today announced it has established a research collaboration with the Harvard Stem Cell Institute’s - Harvard Fibrosis Network to discover new ways of treating fibrotic diseases such as idiopathic pulmonary fibrosis (IPF), chronic...

Rare stem cells (in red) that give rise to scar-tissue secreting myofibroblast cells, here found near the blood vessels of a mouse kidney (in green). (Credit: Rafael Kramann, MD) Harvard team identifies rare stem cells that give rise to chronic tissue...